Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity.

Morsy, H; Taha, E A; Nigm, D A; Shahin, R; Youssef, E M K

Morsy, H; Taha, E A; Nigm, D A; Shahin, R; Youssef, E M K.

Afiliação

Morsy H; Department of Dermatology, Venereology and Andrology , Assiut University, Egypt.
Taha EA; Department of Dermatology, Venereology and Andrology , Assiut University, Egypt.
Nigm DA; Department of Clinical Pathology, Faculty of Medicine, Assiut University, Egypt.
Shahin R; Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Egypt.
Youssef EMK; Department of Dermatology, Venereology and Andrology , Assiut University, Egypt.

Clin Exp Dermatol ; 42(8): 868-873, 2017 Dec.

Article em En | MEDLINE | ID: mdl-28940568

Assuntos

Eritema Multiforme/sangue; Interleucina-17/sangue; Síndrome de Stevens-Johnson/sangue; Adulto; Estudos de Casos e Controles; Eritema Multiforme/classificação; Feminino; Humanos; Masculino; Índice de Gravidade de Doença; Síndrome de Stevens-Johnson/classificação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google